Search

Your search keyword '"Drug Monitoring"' showing total 24 results
Start Over Descriptor "Drug Monitoring" Publication Type Reviews
24 results on '"Drug Monitoring"'

1. Belantamab Mafodotin-blmf.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *ANTINEOPLASTIC agents, *DRUG interactions, *DRUG monitoring, *DOSAGE forms of drugs, *INJECTIONS, *INTRAVENOUS therapy, *MONOCLONAL antibodies, *MULTIPLE myeloma, *PATIENT education, *PHARMACY information services, *DRUG approval
Abstract

The article offers information on the antineoplastic drug Blenrep (Belantamab Mafodotin-blmf) from GlaxoSmithKline LLC including its uses, dosage form and strength, mechanism of action, the precautions related to lactation, pediatric use, and renal impairment, and the common adverse effects.

Published
2020
Full Text
View/download PDF

2. New Drugs 2016 PART 3.

Author

Hussar, Daniel A.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *DRUG therapy for asthma, *ADIPOSE tissues, *ALKALINE phosphatase, *ANTINEOPLASTIC agents, *ANTIEMETICS, *CANCER chemotherapy, *COMBINATION drug therapy, *CHIN, *CYSTIC fibrosis, *DRUG interactions, *DRUG monitoring, *DRUGS, *DRUG administration, *DOSAGE forms of drugs, *ESTERASES, *GENETIC techniques, *IMIDAZOLES, *IRRITABLE colon, *MONOCLONAL antibodies, *MYOCARDIAL revascularization, *PATIENT education, *RARE diseases, *PLASTIC surgery, *TRANSLUMINAL angioplasty, *CONTINUING education units, *PLATELET aggregation inhibitors, *NURSING interventions, *PHARMACODYNAMICS, *THERAPEUTICS
Abstract

The article offers information about drugs approved by the U.S. Food and Drug Administration (FDA) as of September 2016, including Eluxadoline with brand name Viberzi from pharmaceutical company Allergan, Rolapitant hydrochloride with brand name Varubi from pharmaceutical company Tesaro, and Cangrelor with brand name Kengreal from The Medicines Company.

Published
2016
Full Text
View/download PDF

3. New Drugs 2016 PART 1.

Author

Hussar, Daniel A.

Subjects
*BACTERIAL diseases, *DRUG therapy, *DRUG dosage, *STROKE prevention, *SUBCUTANEOUS injections, *ANALGESICS, *ANTICOAGULANTS, *ATRIAL fibrillation, *COMBINATION drug therapy, *CONSTIPATION, *DRUG interactions, *DRUG monitoring, *DRUGS, *ENZYME inhibitors, *HEART failure, *INSOMNIA, *INTRAVENOUS therapy, *MONOCLONAL antibodies, *NALOXONE, *NARCOTICS, *NEUROTRANSMITTERS, *ORAL drug administration, *PATIENT education, *PRODRUGS, *PSORIASIS, *PULMONARY embolism, *VENOUS thrombosis, *DRUG approval, *CONTINUING education units, *VALSARTAN, *CEFTAZIDIME, *PHARMACODYNAMICS
Abstract

The article evaluates drugs approved by the U.S. Food and Drug Administration as of April 2016 including sacubtril/valsartan or Entresto from Novartis for heart failure (HF), ivabradine hydrochloride or Corlanor from Amgen from HF, and naloxegol oxalate or Movantik from Astra-Zeneca for opioid-induced constipation.

Published
2016
Full Text
View/download PDF

4. New Drugs 2015 PART 2.

Author

Hussar, Daniel A.

Subjects
*HYPOGLYCEMIA, *THROMBOSIS prevention, *SUBCUTANEOUS injections, *ANTI-infective agents, *BLINDNESS, *BLOOD platelet aggregation, *CELL receptors, *COMMUNICABLE diseases, *DIABETES, *DRUG interactions, *DRUG monitoring, *DRUGS, *DRUG administration, *HYPOGLYCEMIC agents, *INFLAMMATORY bowel diseases, *INTRAVENOUS therapy, *METABOLIC regulation, *MONOCLONAL antibodies, *TYPE 2 diabetes, *NURSING practice, *ORAL drug administration, *PATIENT education, *SKIN diseases, *SLEEP disorders, *SOLUTION (Chemistry), *DRUG tablets, *CONTINUING education units, *PLATELET aggregation inhibitors, *GLUCAGON-like peptide-1 agonists, *DISEASE complications, *PHARMACODYNAMICS, *PREVENTION
Abstract

The article offers information several drugs which are approved by the U.S. Food & Drug Administration, including Tedizolid phosphate used for skin infection treatment, from Cubist, antidiabetic agent Empagliflozin from Boehringer Ingelheim and Lilly, and Vedolizumab for curing ulcerative colitis.

Published
2015
Full Text
View/download PDF

5. How participants in cancer trials are chosen: ethics and conflicting interests.

Author

Jayson, Gordon and Harris, John

Subjects
*CLINICAL drug trials, *CLINICAL trials, *CLINICAL medicine research, *DRUG monitoring, *CANCER treatment, *CLINICAL pharmacology
Abstract

The development of new drugs for cancer is extremely complex and expensive, and poses ethical problems. In this article we will review issues in clinical trials for cancer drugs that will cast new light on the doctor-patient relationship and their interaction with industry, the health service, academic and administrative organizations. We show that the Declaration of Helsinki cannot be applied to cancer trials as it is currently written, that patients do not and perhaps cannot give fully informed consent to participate, and that the results of clinical trials do not translate into daily practice in a way that patients might expect. [ABSTRACT FROM AUTHOR]

Published
2006
Full Text
View/download PDF

6. A Striking Look into the Invisible World of Phase 1 Clinical Trials: A Book Review of Jill Fisher's Adverse Events.

Author

Richards, Rebecca

Subjects
*CLINICAL trials, *LABORATORY rats, *DRUG monitoring, *RACIAL inequality, *COVID-19 vaccines
Abstract

It is her analysis of how the latter process is instrumental in not only providing the Phase 1 industry with ready access to a pool of dedicated volunteers but also serves to generate data that presents pharmaceutical products in the best and safest way, that demonstrates how social inequalities are exploited for systematic profiteering by the pharmaceutical sector. This quote succinctly encapsulates the argument laid out in Jill A. Fisher's "Adverse Events": the Phase 1 clinical trial industry in the US not only relies upon but also exploits the social inequalities of the society in which it operates. [Extracted from the article]

Published
2021
Full Text
View/download PDF

7. DRUG Watch.

Author

Aschenbrenner, Diane S.

Subjects
*THERAPEUTIC use of monoclonal antibodies, *STROKE prevention, *SUBCUTANEOUS injections, *ANTICOAGULANTS, *BLOOD coagulation tests, *DRUG monitoring, *DRUGS, *DRUG administration, *MONOCLONAL antibodies, *ORAL drug administration, *PATIENT education, *PSORIASIS, *PULMONARY embolism, *VENOUS thrombosis
Abstract

The article offers brief information on the monoclonal antibody Secukinumab and oral anticoagulant Edoxaban.

Published
2015

8. Book Review: Fundamentals of Analytical Toxicology: Clinical and Forensic, Second Edition.

Author

Budny, John A.

Subjects
*FORENSIC toxicology, *CLINICAL toxicology, *PROBLEM solving, *DRUG monitoring, *NURTURING behavior
Abstract

These 6 chapters cover the analytical techniques that are normally used in the definitive identification and quantification of toxicants. Closer to the discussion here, toxicology and its practice is very much like a coin: adverse effects of a toxicant and the amount of the toxicant to cause the adverse effects are both necessary to explain the complete realm of toxicity. Investigating I Fundamentals of Analytical Toxicology, Second Edition i , brings into focus 3 necessary dimensions of toxicology: (1) the adverse effects caused by a toxicant; (2) the level of the toxicant that causes the adverse effects; and (3) the level of the toxicant at which no adverse effects are seen. [Extracted from the article]

Published
2021
Full Text
View/download PDF

9. Web Wanderings.

Author

Woldin, Barbara

Subjects
*ASSOCIATIONS, institutions, etc., *DRUG monitoring
Abstract

The article reviews several web sites of interest to U.S. medical writers, including the sites of the Agency for Healthcare Research and Quality at www.ahrq.gov, MediLexicon at www.medilexicon.com, and the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use at www.ich.org.

Published
2010

10. Menu, methods, and more for 29 analyzers.

Author

Eberhard, Kristen

Subjects
*PROTEIN analysis, *DRUG monitoring, *EQUIPMENT & supplies
Abstract

The article evaluates various analyzers including protein analyzer Optilite from Binding Site, chemistry analyzers AU480, AU680, and AU5800 from Beckman Coulter; and immunosuppressant therapeutic drug monitoring assays Thermo Fisher Scientific.

Published
2015

11. Drug-offender monitoring comes to the smartphone.

Author

Dysart, Joe

Subjects
*MOBILE apps, *DRUG monitoring, *COMPUTER software
Abstract

The article evaluates the new Smartphone application Outreach Smartphone Monitoring (OSM) invented by Mike Kingery, which assists in monitoring and testing of drug-offenders by a surprise Breathalyzer test and on-the-spot tests of their blood alcohol levels.

Published
2015

12. New Products.

Subjects
*CLINICAL trials, *SIMULATION methods & models, *DRUG monitoring, *EQUIPMENT & supplies
Abstract

The article discusses the release of two products related to applied clinical trials including a study simulation and forecasting service by Cenduit LLC and the I-Accountability, a drug accountability system for tracking and controlling drug inventory, by PharmaVigilant.

Published
2013

13. Behavioural Neurology of Antiepileptic Drugs: A Practical Guide.

Author

Mula, Marco

Subjects
ANTICONVULSANTS, NEUROLOGY, DRUG monitoring
Abstract

Anti-epileptic drugs are widely prescribed in neurology and psychiatry. It is therefore evident that any practising neurologist or psychiatrist has or will have patients taking at least one of these drugs. Neurology and psychiatry trainees will find this guide very informative and of great value in their training. [Extracted from the article]

Published
2020
Full Text
View/download PDF

23. Drug Monitoring.

Author

Harris, E. L.

Subjects
DRUG monitoring, NONFICTION
Abstract

The article reviews the book "Drug Monitoring," edited by F. H. Gross and W. H. W. Inman.

Published
1978
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results